These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38626660)
21. Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical Carcinoma. Boilève A; Mathy E; Roux C; Faron M; Hadoux J; Tselikas L; Al Ghuzlan A; Hescot S; Leboulleux S; de Baere T; Lamartina L; Deschamps F; Baudin E J Clin Endocrinol Metab; 2021 Oct; 106(11):e4698-e4707. PubMed ID: 34143888 [TBL] [Abstract][Full Text] [Related]
22. Prognostic factors of adrenocortical carcinoma in children and adolescents: a population-based study. Jiang Z; Zhou B; Zhang C; Wang C Int Urol Nephrol; 2024 Sep; 56(9):2811-2817. PubMed ID: 38653853 [TBL] [Abstract][Full Text] [Related]
23. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma. Sabolch A; Else T; Griffith KA; Ben-Josef E; Williams A; Miller BS; Worden F; Hammer GD; Jolly S Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):252-9. PubMed ID: 25754631 [TBL] [Abstract][Full Text] [Related]
24. A novel staging system for adrenocortical carcinoma better predicts survival in patients with stage I/II disease. Asare EA; Wang TS; Winchester DP; Mallin K; Kebebew E; Sturgeon C Surgery; 2014 Dec; 156(6):1378-85; discussion 1385-6. PubMed ID: 25456914 [TBL] [Abstract][Full Text] [Related]
25. Association between preoperative serum albumin and prognosis in patients with adrenocortical carcinoma after primary resection: a retrospective study. Zhang F; Liu Z; Liang J; Liu S; Wu K; Zhang F; Zhou C; Lu Y; Zhu Y; Wang X BMC Cancer; 2021 Aug; 21(1):961. PubMed ID: 34445989 [TBL] [Abstract][Full Text] [Related]
26. Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M Eur Urol; 2014 Apr; 65(4):832-8. PubMed ID: 24268504 [TBL] [Abstract][Full Text] [Related]
27. Resection of adrenocortical carcinoma liver metastasis: is it justified? Gaujoux S; Al-Ahmadie H; Allen PJ; Gonen M; Shia J; D'Angelica M; Dematteo R; Fong Y; Blumgart L; Jarnagin WR Ann Surg Oncol; 2012 Aug; 19(8):2643-51. PubMed ID: 22526905 [TBL] [Abstract][Full Text] [Related]
28. Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis. Naffouje SA; Sabesan A; Hallanger-Johnson J; Kirtane K; Gonzalez RJ; Mullinax J J Surg Oncol; 2021 Dec; 124(8):1261-1271. PubMed ID: 34424540 [TBL] [Abstract][Full Text] [Related]
29. Impact of Laparoscopic Adrenalectomy on Overall Survival in Patients with Nonmetastatic Adrenocortical Carcinoma. Huynh KT; Lee DY; Lau BJ; Flaherty DC; Lee J; Goldfarb M J Am Coll Surg; 2016 Sep; 223(3):485-92. PubMed ID: 27238874 [TBL] [Abstract][Full Text] [Related]
30. A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study. Kong J; Zheng J; Cai J; Wu S; Diao X; Xie W; Chen X; Liao C; Yu H; Fan X; Huang C; Liu Z; Chen W; Lv Q; Qin H; Huang J; Lin T Cancer Commun (Lond); 2019 Nov; 39(1):80. PubMed ID: 31775884 [TBL] [Abstract][Full Text] [Related]
31. National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress? Tierney JF; Chivukula SV; Poirier J; Pappas SG; Schadde E; Hertl M; Kebebew E; Keutgen X J Clin Endocrinol Metab; 2019 Dec; 104(12):5948-5956. PubMed ID: 31361313 [TBL] [Abstract][Full Text] [Related]
32. Diagnosis, treatment, and survival analysis of adrenocortical carcinomas: a multicentric study. Souteiro P; Donato S; Costa C; Pereira CA; Simões-Pereira J; Oliveira J; Belo S; Santos AP; Cardoso H; Leite V; Carvalho D; Torres I Hormones (Athens); 2020 Jun; 19(2):197-203. PubMed ID: 31823340 [TBL] [Abstract][Full Text] [Related]
33. The long-term survival in adrenocortical carcinoma with active surgical management and use of monitored mitotane. Wängberg B; Khorram-Manesh A; Jansson S; Nilsson B; Nilsson O; Jakobsson CE; Lindstedt S; Odén A; Ahlman H Endocr Relat Cancer; 2010 Mar; 17(1):265-72. PubMed ID: 20026647 [TBL] [Abstract][Full Text] [Related]
34. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach. Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101 [TBL] [Abstract][Full Text] [Related]
35. Treatment of Adrenocortical Carcinoma. Vaidya A; Nehs M; Kilbridge K Surg Pathol Clin; 2019 Dec; 12(4):997-1006. PubMed ID: 31672303 [TBL] [Abstract][Full Text] [Related]
36. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma. Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M; Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204 [TBL] [Abstract][Full Text] [Related]
37. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179 [TBL] [Abstract][Full Text] [Related]
38. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757 [TBL] [Abstract][Full Text] [Related]
39. S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL Eur J Endocrinol; 2021 Nov; 186(1):25-36. PubMed ID: 34709200 [TBL] [Abstract][Full Text] [Related]
40. Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. Calabrese A; Basile V; Puglisi S; Perotti P; Pia A; Saba L; Berchialla P; Porpiglia F; Veltri A; Volante M; Reimondo G; Berruti A; Terzolo M Eur J Endocrinol; 2019 Jun; 180(6):387-396. PubMed ID: 30991359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]